Biotech · Private company · Oak Park, IL, US
Ikaika Therapeutics Inc
Track this companyFree. Adds Ikaika Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Preclinical development of anti-LTPB4 monoclonal antibodies to treat Neuromuscular DiseasesFiscal year 2026 · $995.9KNIH RePORTER 1R44AR087317-01 · fetched Nov 12, 2026